Literature DB >> 31466681

Newborn Screening for Severe Combined Immunodeficiency.

Mohammed Taki1, Tayaba Miah1, Elizabeth Secord2.   

Abstract

The T-cell receptor excision circle (TREC) assay is an effective screening tool for severe combined immunodeficiency (SCID). The TREC assay was designed to detect typical SCID and leaky SCID, but any condition causing low naïve T-cell counts will also be detected. Newborn screening for SCID using the TREC assay has proven itself to be highly sensitive and cost-efficient. This review covers the history of SCID newborn screening, elaborates on the SCID subtypes and TREC assay limitations, and discusses diagnostic and management considerations for infants with a positive screen.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Newborn screening (NBS); Severe combined immunodeficiency (SCID); T-cell lymphopenia; T-cell receptor excision circle (tREC)

Mesh:

Year:  2019        PMID: 31466681     DOI: 10.1016/j.pcl.2019.06.007

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  3 in total

Review 1.  Review of Treatment for Adenosine Deaminase Deficiency (ADA) Severe Combined Immunodeficiency (SCID).

Authors:  Elizabeth Secord; Nicholas L Hartog
Journal:  Ther Clin Risk Manag       Date:  2022-09-22       Impact factor: 2.755

2.  The co-occurrence of Wilson disease and X-linked agammaglobulinemia in one family highlights the promising diagnostic potential of proteolytic analysis.

Authors:  Sheri A Poskanzer; Jenny Thies; Christopher J Collins; Candace T Myers; Remwilyn Dayuha; Phi Duong; Fan Yi; Irene J Chang; Hans D Ochs; Troy R Torgerson; Si Houn Hahn
Journal:  Mol Genet Genomic Med       Date:  2020-02-17       Impact factor: 2.183

Review 3.  Combined immunodeficiencies.

Authors:  Carolina Sanchez Aranda; Rafaela Rola Guimarães; Mariana de Gouveia-Pereira Pimentel
Journal:  J Pediatr (Rio J)       Date:  2020-12-17       Impact factor: 2.990

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.